Pharmacology in Pediatric Renal Solid Organ Transplantation

Christine Tabulov1, Kelly McGee2, Beatriz Fabiola Marin Ruiz3

  • 1Department of Pharmacotherapeutics and Clinical Research, University of South Florida Taneja College of Pharmacy, 12901 Bruce B. Downs Boulevard, MDC 30, Tampa, FL 33612, USA.

PubMed

Insights

Managing immunosuppression in pediatric kidney transplants is key to prevent rejection and side effects. Careful dosing, patient education, and team collaboration improve outcomes for children undergoing renal transplantation.

Area of Science:

  • Pediatric Nephrology
  • Transplantation Immunology
  • Pharmacology

Background:

  • Pediatric renal transplantation requires careful immunosuppression management.
  • Balancing graft survival with infection and cancer risks is crucial.
  • Children's unique growth and developmental needs complicate treatment.

Purpose of the Study:

  • To review induction and maintenance immunosuppression agents in pediatric kidney transplant recipients.
  • To highlight challenges specific to pediatric immunosuppression.
  • To emphasize the importance of multidisciplinary care for long-term graft survival.

Main Methods:

  • Literature review of immunosuppression strategies.
  • Analysis of induction and maintenance protocols.
  • Discussion of pediatric-specific considerations.

Main Results:

  • Various immunosuppression agents are available for induction and maintenance therapy.
  • Pediatric patients require tailored dosing and vigilant monitoring.
  • Caregiver education and multidisciplinary collaboration are vital.

Conclusions:

  • Effective immunosuppression management is critical for pediatric renal transplant success.
  • Addressing unique pediatric challenges optimizes patient outcomes and graft survival.
  • A collaborative, multidisciplinary approach ensures comprehensive care for this population.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
65
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
78
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
85
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
371
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
166
Renal Drug Clearance: Overview01:06

Renal Drug Clearance: Overview

Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
346